Skip to content
Find a Provider
Kimberly Gergelis, M.D.

Kimberly Gergelis, M.D.

Radiation Oncology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Call Center (585) 276-3000

Locations

Pluta Cancer Center

125 Red Creek Drive
Rochester, NY 14623

Get Directions
Wilmot Cancer Center

90 Crittenden Boulevard
Rochester, NY 14642

(585) 275-5830 Get Directions
Wilmot Cancer Institute

1000 South Avenue
Rochester, NY 14620

Get Directions

About Me

Certified Specialties

Radiation Oncology - American Board of Radiology

Faculty Appointments

Assistant Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Resident, Mayo Clinic. 2018 - 2022

Internship, Internal Medicine, Stamford Health System. 2017 - 2018

Education

MD | Yeshiva University Albert Einstein College of Medicine. 2017

Awards

Christina M. Frechette Patient Experience Award. 2022

Mayo Fellows' Association Humanitarian Award. 2022

Department of Radiation Oncology Inaugural Well-Being Scholarship Award. 2021

School of Graduate Medical Education CLER Distinguished Fellow Well-Being Award. 2021

Glasgow-Rubin Citation for Academic Achievement. 2017

Alpha Omega Alpha. 2016

Julius Gerwitz Scholar. 2013 - 2017

Lucien and Ethel Brownstone Scholar. 2013 - 2017

Mark I. Finkelstein Scholar. 2013 - 2017

Class of 1960 Scholar. 2013 - 2017

Chemistry Alumni Scholarship. 2012

Ralph Theurer Scholarship for Excellence in Chemistry. 2011

Michael Bauda Memorial Scholarship. 2009

University at Buffalo Provost Scholarship. 2008 - 2012

Research

Clinical Trials

A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO)

Lead Researcher: Kimberly Gergelis

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast ...

Publications

Journal Articles

De-escalation of axillary surgery in patients outside Z0011 criteria.

Giannakou A, Gooch J, Gergelis KR, Weiss A

Surgery.. 2023 August 174 (2):416-418. Epub 05/06/2023.

Sinonasal mucosal melanoma: An analysis of treatment-related adverse events and associated factors.

Johnson BJ, Guo R, Moore EJ, Price DL, Van Abel KM, Van Gompel JJ, Link MJ, Peris-Celda M, Stokken JK, Pinheiro-Neto C, Kottschade L, Markovic S, Block M, McWilliams R, Montane H, Dimou A, Gergelis K, Gamez ME, Choby G

International forum of allergy & rhinology.. 2023 June 13 (6):1037-1041. Epub 12/15/2022.

Postmastectomy intensity modulated proton therapy: 5-year oncologic and patient-reported outcomes

Gao RW; Mullikin TC; Aziz KA; Afzal A; Smith NL; Routman DM; Gergelis KR; Harmsen WS; Remmes NB; Tseung HSWC; Shiraishi SS; Boughey JC; Ruddy KJ; Harless CA; Garda AE; Waddle MR; Park SS; Shumway DA; Corbin KS; Mutter RW.

Int J Radiat Oncol Biol Phys. 2023; 117(4): 846-856.

Radiation-based, multi-modality therapy for elderly patients with muscle-invasive bladder cancer: Utility, Rationale, and Efficacy

Gergelis KR; Breen WG; Choo R.

European Society of Medicine Medical Research Archives. 2022; 10(1): 2647.

Integrating a Grassroots Well-Being Curriculum into a Radiation Oncology Residency Program.

Gergelis KR, Anand US, Rian JS, Roberts KW, Quinones PJ, Olivier KR, Corbin KS, Stonnington CM

Advances in radiation oncology.. 2022 7 (1):100837. Epub 10/27/2021.

Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity.

Breen WG, Jeans EB, Gergelis KR, Garces YI, Park SS, Merrell KW, Peikert TD, Mansfield AS, Wigle DA, Harmsen WS, Ellerbusch DC, Olivier KR, John Lucido J, Owen D

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2021 May 158 :246-252. Epub 03/10/2021.

Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective Study.

Lee G, Kim DW, Oladeru OT, Niemierko A, Gergelis KR, Haddock MG, Toesca DAS, Koong AJ, Owen D, Weekes C, Hong TS, Chang DT, Hallemeier CL, Wo JY

Pancreas.. 2021 50 (5):736-743. Epub 1900 01 01.

Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.

Bai M, Gergelis KR, Sir M, Whitaker TJ, Routman DM, Stish BJ, Davis BJ, Pisansky TM, Choo R

Cancer medicine. 2020 November 9 (21):7925-7934. Epub 09/15/2020.

Proton beam radiotherapy for esophagus cancer: state of the art.

Gergelis KR, Jethwa KR, Tryggestad EJ, Ashman JB, Haddock MG, Hallemeier CL

Journal of thoracic disease.. 2020 November 12 (11):7002-7010. Epub 1900 01 01.

Outcomes and Profiles of Older Patients Receiving Definitive Radiation Therapy for Muscle-Invasive Bladder Cancer at a Tertiary Medical Center.

Gergelis KR, Kreofsky CR, Choo CS, Viehman J, Harmsen WS, Lester SC, Pisansky TM, Davis BJ, Stish BJ, Choo R

Practical radiation oncology.. 2020 10 (5):e378-e387. Epub 02/26/2020.

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT.

Gergelis KR, Remme DS, Choo CR

Urology case reports.. 2019 September 26 :100985. Epub 07/31/2019.

High-grade Ductal Carcinoma In Situ (DCIS) of the Male Breast Treated with Breast Conserving Therapy

Young R; Gergelis K; Kalnicki S; Fox JL.

Ann Clin Case Rep. 2017; 2: 1383.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.